PubMed

Secretory phospholipase a(2): a multifaceted family of proatherogenic enzymes.

Rosenson RS, Gelb MH.

Curr Cardiol Rep. 2009 Nov;11(6):445-51.PMID: 19863869 [PubMed - in process]Related articles

Residual microvascular risk in diabetes: unmet needs and future directions.

Fioretto P, Dodson PM, Ziegler D, Rosenson RS.

Nat Rev Endocrinol. 2009 Oct 27. [Epub ahead of print]PMID: 19859073 [PubMed - as supplied by publisher]Related articles

Treatment of hypertension in metabolic syndrome subjects with amlodipine and olmesartan-effects on oxidized non-esterified free fatty acids and cytokine production.

Rosenson RS.

Cardiovasc Drugs Ther. 2009 Aug;23(4):289-94.PMID: 19641984 [PubMed - indexed for MEDLINE]Related articles

Role of the endocannabinoid system in abdominal obesity and the implications for cardiovascular risk.

Rosenson RS.

Cardiology. 2009;114(3):212-25. Epub 2009 Jul 29.PMID: 19641317 [PubMed - in process]Related articles

Management of non-high-density lipoprotein abnormalities.

Rosenson RS.

Atherosclerosis. 2009 May 27. [Epub ahead of print]PMID: 19545870 [PubMed - as supplied by publisher]Related articles

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.

McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J; American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association.

J Am Coll Cardiol. 2009 Apr 28;53(17):1573-619. No abstract available. PMID: 19389575 [PubMed - indexed for MEDLINE]Related articles

Vascular biomarkers in the metabolic syndrome.

Thande N, Rosenson RS.

Expert Rev Mol Diagn. 2009 Apr;9(3):209-15. No abstract available. PMID: 19379078 [PubMed - indexed for MEDLINE]Related articles

A treasure of pharmacogenomic insights into postprandial lipoproteinemia and therapeutic responses to fibrate therapy: lessons from GOLDN.

Rosenson RS.

Curr Atheroscler Rep. 2009 May;11(3):161-4. No abstract available. PMID: 19361346 [PubMed - indexed for MEDLINE]Related articles

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association.

McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J, Harrington RA, Anderson JL, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Grines CL, Hlatky MA, Jacobs AK, Kaul S, Lichtenberg RC, Lindner JR, Moliterno DJ, Mukherjee D, Pohost GM, Rosenson RS, Schofield RS, Shubrooks SJ, Stein JH, Tracy CM, Weitz HH, Wesley DJ; ACCF/AHA.

Circulation. 2009 Apr 28;119(16):2250-94. Epub 2009 Mar 30. Review. No abstract available. Erratum in: Circulation. 2009 Jul 14;120(2):e13. PMID: 19332472 [PubMed - indexed for MEDLINE]Related articles

Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled study.

Rosenson RS, Otvos JD, Hsia J.

Diabetes Care. 2009 Jun;32(6):1087-91. Epub 2009 Mar 5.PMID: 19265025 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial.

Rosenson RS, Hislop C, McConnell D, Elliott M, Stasiv Y, Wang N, Waters DD; PLASMA Investigators.

Lancet. 2009 Feb 21;373(9664):649-58. Erratum in: Lancet. 2009 May 9-2009 May15;373(9675):1606. PMID: 19231633 [PubMed - indexed for MEDLINE]Related articles

Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.

Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, Ridker PM.

Circulation. 2009 Feb 24;119(7):931-9. Epub 2009 Feb 9.PMID: 19204302 [PubMed - indexed for MEDLINE]Related articles

Future role for selective phospholipase A2 inhibitors in the prevention of atherosclerotic cardiovascular disease.

Rosenson RS.

Cardiovasc Drugs Ther. 2009 Feb;23(1):93-101. Epub 2009 Jan 14. Review. No abstract available. PMID: 19153679 [PubMed - indexed for MEDLINE]Related articles

Management of hyperlipidemia in older adults.

Alexander KP, Blazing MA, Rosenson RS, Hazard E, Aronow WS, Smith SC Jr, Ohman EM.

J Cardiovasc Pharmacol Ther. 2009 Mar;14(1):49-58. Epub 2009 Jan 5. Review.PMID: 19124599 [PubMed - indexed for MEDLINE]Related articles

Triglycerides and cardiovascular events in ACS: the need for combined lipid-altering therapies.

Rosenson RS, Pitt B.

Nat Clin Pract Cardiovasc Med. 2009 Feb;6(2):98-100. Epub 2008 Dec 17. No abstract available. PMID: 19079366 [PubMed - indexed for MEDLINE]Related articles

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.

Fruchart JC, Sacks F, Hermans MP, Assmann G, Brown WV, Ceska R, Chapman MJ, Dodson PM, Fioretto P, Ginsberg HN, Kadowaki T, Lablanche JM, Marx N, Plutzky J, Reiner Z, Rosenson RS, Staels B, Stock JK, Sy R, Wanner C, Zambon A, Zimmet P.

Am J Cardiol. 2008 Nov 17;102(10 Suppl):1K-34K. Review.PMID: 19068318 [PubMed - indexed for MEDLINE]Related articles

Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients.

Rosenson RS.

Obesity (Silver Spring). 2009 Mar;17(3):504-9. Epub 2008 Nov 20.PMID: 19023279 [PubMed - indexed for MEDLINE]Related articles

Fenofibrate: treatment of hyperlipidemia and beyond.

Rosenson RS.

Expert Rev Cardiovasc Ther. 2008 Nov;6(10):1319-30. Review.PMID: 19018684 [PubMed - indexed for MEDLINE]Related articles

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM, Harrington RA, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Hlatky MA, Kaul S, Lindner JR, Moliterno DJ, Mukherjee D, Schofield RS, Rosenson RS, Stein JH, Weitz HH, Wesley DJ; American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

J Am Coll Cardiol. 2008 Oct 28;52(18):1502-17. No abstract available. PMID: 19017521 [PubMed - indexed for MEDLINE]Related articles

Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes.

Rosenson RS, Abby SL, Jones MR.

Atherosclerosis. 2009 Jun;204(2):342-4. Epub 2008 Oct 5.PMID: 18996525 [PubMed - indexed for MEDLINE]Related articles

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient.

Fruchart JC, Sacks FM, Hermans MP, Assmann G, Brown WV, Ceska R, Chapman MJ, Dodson PM, Fioretto P, Ginsberg HN, Kadowaki T, Lablanche JM, Marx N, Plutzky J, Reiner Z, Rosenson RS, Staels B, Stock JK, Sy R, Wanner C, Zambon A, Zimmet P; Residual Risk Reduction Initiative (R3I).

Diab Vasc Dis Res. 2008 Nov;5(4):319-35. Review.PMID: 18958843 [PubMed - indexed for MEDLINE]Related articles

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.

Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM, Harrington RA, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Hlatky MA, Kaul S, Lindner JR, Moliterno DJ, Mukherjee D, Schofield RS, Rosenson RS, Stein JH, Weitz HH, Wesley DJ; American College of Cardiology Foundation; American College of Gastroenterology; American Heart Association.

Am J Gastroenterol. 2008 Nov;103(11):2890-907. Epub 2008 Oct 3. No abstract available. PMID: 18853965 [PubMed - indexed for MEDLINE]Related articles

Treatment with aspirin and dipyridamole is more effective than aspirin in reducing low shear blood viscosity.

Rosenson RS.

Microcirculation. 2008 Oct;15(7):615-20.PMID: 18788038 [PubMed - indexed for MEDLINE]Related articles

Biomarkers, atherosclerosis and cardiovascular events.

Rosenson RS.

Expert Rev Cardiovasc Ther. 2008 Jun;6(5):619-22. Review.PMID: 18510479 [PubMed - indexed for MEDLINE]Related articles

Off-target toxicity: risks associated with adrenal corticoid activation in ILLUMINATE.

Rosenson RS.

Curr Atheroscler Rep. 2008 Jun;10(3):227-9. No abstract available. PMID: 18489850 [PubMed]Related articles

Fenofibrate reduces lipoprotein associated phospholipase A2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome.

Rosenson RS.

Am Heart J. 2008 Mar;155(3):499.e9-16. Epub 2008 Jan 31.PMID: 18294485 [PubMed - indexed for MEDLINE]Related articles

Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome.

Rosenson RS, Huskin AL, Wolff DA, Helenowski IB, Rademaker AW.

Atherosclerosis. 2008 Jun;198(2):381-8. Epub 2008 Feb 1.PMID: 18242616 [PubMed - indexed for MEDLINE]Related articles

SPARCL: statin therapy for stroke patients is not crystal clear.

Rosenson RS.

Curr Atheroscler Rep. 2007 Sep;9(3):213-5. No abstract available. PMID: 18241615 [PubMed]Related articles

Lipoprotein associated phospholipase A2 inhibition reduces generation of oxidized fatty acids: Lp-LPA2 reduces oxidized fatty acids.

Rosenson RS, Vracar-Grabar M, Helenowski I.

Cardiovasc Drugs Ther. 2008 Feb;22(1):55-8. Epub 2008 Jan 23.PMID: 18214661 [PubMed - indexed for MEDLINE]Related articles

Avoiding the looming Latino/Hispanic cardiovascular health crisis: a call to action.

Davidson JA, Kannel WB, Lopez-Candales A, Morales L, Moreno PR, Ovalle F, Rodriguez CJ, Rodbard HW, Rosenson RS, Stern M.

J Cardiometab Syndr. 2007 Fall;2(4):238-43. Review.PMID: 18059205 [PubMed - indexed for MEDLINE]Related articles

Avoiding the looming Latino/Hispanic cardiovascular health crisis: a call to action.

Davidson JA, Kannel WB, Lopez-Candales A, Morales L, Moreno PR, Ovalle F, Rodriguez CJ, Rodbard HW, Rosenson RS, Stern M.

Ethn Dis. 2007 Summer;17(3):568-73. Review.PMID: 17985515 [PubMed - indexed for MEDLINE]Related articles

Vascular and metabolic effects of treatment of combined hyperlipidemia: focus on statins and fibrates.

Koh KK, Quon MJ, Rosenson RS, Chung WJ, Han SH.

Int J Cardiol. 2008 Feb 29;124(2):149-59. Epub 2007 Jul 20. Review.PMID: 17658632 [PubMed - indexed for MEDLINE]Related articlesFree article

Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome.

Rosenson RS, Wolff DA, Huskin AL, Helenowski IB, Rademaker AW.

Diabetes Care. 2007 Aug;30(8):1945-51. Epub 2007 May 4.PMID: 17483155 [PubMed - indexed for MEDLINE]Related articlesFree article

Statins and sepsis: multiple modifications at multiple levels.

Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG.

Lancet Infect Dis. 2007 May;7(5):358-68. Review.PMID: 17448939 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular disease prevention and care in Latino and Hispanic subjects.

Davidson JA, Moreno PR, Badimon JJ, Lopez-Candales A, Maisonet Giachello AL, Ovalle F, Rodriguez CJ, Rosenson RS, Rodbard HW, Kannel WB.

Endocr Pract. 2007 Jan-Feb;13(1):77-85. Review.PMID: 17360307 [PubMed - indexed for MEDLINE]Related articles

Effects of peroxisome proliferator-activated receptors on lipoprotein metabolism and glucose control in type 2 diabetes mellitus.

Rosenson RS.

Am J Cardiol. 2007 Feb 19;99(4A):96B-104B. Epub 2006 Dec 22. Review.PMID: 17307062 [PubMed - indexed for MEDLINE]Related articles

Measure for measure--sugar or fats? Reconciling cardiovascular and diabetes risk with niacin therapy.

Rosenson RS.

Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):72-3. No abstract available. PMID: 17237831 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of rosuvastatin 40 mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: results of the POLARIS study.

Leiter LA, Rosenson RS, Stein E, Reckless JP, Schulte KL, Schleman M, Miller P, Palmer M, Sosef F; POLARIS study investigators.

Atherosclerosis. 2007 Oct;194(2):e154-64. Epub 2007 Jan 16.PMID: 17229426 [PubMed - indexed for MEDLINE]Related articles

Preanalytical sources of measurement error: the conundrum of the homocysteine hypothesis.

Rosenson RS, Tangney CC.

Atherosclerosis. 2007 Oct;194(2):520. Epub 2006 Nov 15. No abstract available. PMID: 17109864 [PubMed - indexed for MEDLINE]Related articles

Field of confusion: future prospects for fibrate therapy in cardiovascular disease.

Rosenson RS.

Curr Atheroscler Rep. 2006 May;8(3):219-22. No abstract available. PMID: 16640958 [PubMed - indexed for MEDLINE]Related articles

An assessment of statin safety by muscle experts.

Thompson PD, Clarkson PM, Rosenson RS; National Lipid Association Statin Safety Task Force Muscle Safety Expert Panel.

Am J Cardiol. 2006 Apr 17;97(8A):69C-76C. Epub 2006 Feb 9.PMID: 16581332 [PubMed - indexed for MEDLINE]Related articles

Statins: panacea for sepsis?

Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG.

Lancet Infect Dis. 2006 Apr;6(4):242-8. Review.PMID: 16554249 [PubMed - indexed for MEDLINE]Related articles

Low high-density lipoprotein cholesterol and cardiovascular disease: risk reduction with statin therapy.

Rosenson RS.

Am Heart J. 2006 Mar;151(3):556-63.PMID: 16504615 [PubMed - indexed for MEDLINE]Related articles

Acute-phase reactants and coronary heart disease.

Koenig W, Rosenson RS.

Semin Vasc Med. 2002 Nov;2(4):417-28. Review.PMID: 16222631 [PubMed - indexed for MEDLINE]Related articles

Low HDL-C: a secondary target of dyslipidemia therapy.

Rosenson RS.

Am J Med. 2005 Oct;118(10):1067-77. Review.PMID: 16194634 [PubMed - indexed for MEDLINE]Related articles

Assessing risk across the spectrum of patients with the metabolic syndrome.

Rosenson RS.

Am J Cardiol. 2005 Aug 22;96(4A):8E-10E. Review.PMID: 16098836 [PubMed - indexed for MEDLINE]Related articles

Short-term reduction in bone markers with high-dose simvastatin.

Rosenson RS, Tangney CC, Langman CB, Parker TS, Levine DM, Gordon BR.

Osteoporos Int. 2005 Oct;16(10):1272-6. Epub 2005 Aug 9.PMID: 16088363 [PubMed - indexed for MEDLINE]Related articles

Colesevelam HCl reduces LDL particle number and increases LDL size in hypercholesterolemia.

Rosenson RS.

Atherosclerosis. 2006 Apr;185(2):327-30. Epub 2005 Jul 11.PMID: 16009365 [PubMed - indexed for MEDLINE]Related articles

Low high-density lipoprotein cholesterol disorders and cardiovascular risk: contribution of associated low-density lipoprotein subclass abnormalities.

Rosenson RS.

Curr Opin Cardiol. 2005 Jul;20(4):313-7. Review.PMID: 15956829 [PubMed - indexed for MEDLINE]Related articles

HDL-C and the diabetic patient: target for therapeutic intervention?

Rosenson RS.

Diabetes Res Clin Pract. 2005 Jun;68 Suppl 2:S36-42. Epub 2005 Apr 7. Review.PMID: 15953506 [PubMed - indexed for MEDLINE]Related articles